The World Health Organization is considering the use of experimental vaccines and treatments as Ebola cases and deaths rise in the Democratic Republic of the Congo. WHO chief Dr Tedros Adhanom Ghebreyesus said he was “deeply concerned” after hundreds of suspected cases and more than 130 suspected deaths were reported.
Bundibugyo strain raises concern
The outbreak is linked to the Bundibugyo strain of Ebola, for which there is no licensed vaccine or specific approved treatment. WHO says the strain has previously carried high fatality rates, making early detection, isolation and supportive care critical.
Pressure on weak health systems
The outbreak is centred in eastern DRC, where conflict, displacement and limited health infrastructure complicate containment. Health workers face particular risk, while cross-border movement has increased concern in neighbouring countries, including Uganda.
Experimental tools under review
Global health experts are assessing whether candidate vaccines or treatments can be used under emergency protocols. However, vaccine availability remains uncertain, and WHO has warned that a targeted vaccine may take months to become available.
Regional response intensifies
WHO and partners are deploying medical supplies, strengthening surveillance and supporting treatment centres. The immediate priority is to trace contacts, protect health workers and prevent the outbreak from spreading further through communities and across borders.
Newshub Editorial in Africa – 21 May 2026
If you have an account with ChatGPT you get deeper explanations,
background and context related to what you are reading.
Open an account:
Open an account
Recent Comments